Literature DB >> 21967834

Peroxidation of lipoproteins in multiple sclerosis.

Gianna Ferretti1, Tiziana Bacchetti.   

Abstract

Human plasma low density lipoproteins (LDL) and high density lipoproteins (HDL) are involved in the transport of lipids, modulate membrane lipid composition and regulate signal transduction. HDL-like lipoproteins have been shown also in human cerebrospinal fluid and it has been hypothesized that they could have a role in lipid transport in central nervous system. After synthesis, lipoproteins are susceptible to lipid peroxidation triggered by reactive oxygen species (ROS and RNS) produced by peripheral and brain cells. Aim of the paper has been to review the scientific literature on the role of lipid peroxidation of LDL and HDL in the molecular mechanisms of multiple sclerosis (MS). Several studies have demonstrated a significant increase in lipid peroxidation products in brain, plasma and cerebrospinal fluid of MS patients. The increase of antibodies against ox-LDL in plasma and the presence of ox-LDL in demyelinating plaques in MS brain suggests that the disease is associated with oxidative damage of lipoproteins. The impairment of antioxidant systems or an increase in the production of ROS and RNS could contribute to lipoprotein peroxidation in MS. Oxidized lipoproteins show several alterations of their functions, they are neurotoxic and have pro-inflammatory properties. Therefore lipoprotein lipid peroxidation products could be involved in demyelination and axonal injury in MS.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21967834     DOI: 10.1016/j.jns.2011.09.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

1.  Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Dragan Stojanov; Svetlana Stojanovic; Gordana Kocic; Dejan Savic; Tatjana Cvetkovic; Dusica Pavlovic
Journal:  Cell Mol Neurobiol       Date:  2013-05-16       Impact factor: 5.046

2.  Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres.

Authors:  Valeria Bellisario; Giulio Mengozzi; Elena Grignani; Massimiliano Bugiani; Anna Sapino; Gianni Bussolati; Roberto Bono
Journal:  Toxicol Res (Camb)       Date:  2016-04-26       Impact factor: 3.524

Review 3.  Oxidative Stress and Neurobiology of Demyelination.

Authors:  Srdjan Ljubisavljevic
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

Review 4.  Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.

Authors:  Richa Tyagi; Bhupesh Vaidya; Shyam Sunder Sharma
Journal:  Pharmacol Rep       Date:  2022-09-23       Impact factor: 3.919

5.  Edaravone Inhibits the Production of Reactive Oxygen Species in Phagocytosis- and PKC-Stimulated Granulocytes from Multiple Sclerosis Patients Edaravone Modulate Oxidative Stress in Multiple Sclerosis.

Authors:  Pedro Henrique Villar-Delfino; Nathália Augusta Oliveira Gomes; Paulo Pereira Christo; José Augusto Nogueira-Machado; Caroline Maria Oliveira Volpe
Journal:  J Cent Nerv Syst Dis       Date:  2022-05-16

Review 6.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

7.  Aggregation of MBP in chronic demyelination.

Authors:  Kati Frid; Ofira Einstein; Yael Friedman-Levi; Orli Binyamin; Tamir Ben-Hur; Ruth Gabizon
Journal:  Ann Clin Transl Neurol       Date:  2015-06-06       Impact factor: 4.511

8.  Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis.

Authors:  Josephe Archie Honorat; Makoto Kinoshita; Tatsusada Okuno; Kazushiro Takata; Toru Koda; Satoru Tada; Takashi Shirakura; Harutoshi Fujimura; Hideki Mochizuki; Saburo Sakoda; Yuji Nakatsuji
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

9.  Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.

Authors:  Orli Binyamin; Liraz Larush; Kati Frid; Guy Keller; Yael Friedman-Levi; Haim Ovadia; Oded Abramsky; Shlomo Magdassi; Ruth Gabizon
Journal:  Int J Nanomedicine       Date:  2015-11-20

10.  Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.

Authors:  Cornelia Schuh; Isabella Wimmer; Simon Hametner; Lukas Haider; Anne-Marie Van Dam; Roland S Liblau; Ken J Smith; Lesley Probert; Christoph J Binder; Jan Bauer; Monika Bradl; Don Mahad; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2014-03-13       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.